Earth Science Tech (OTCMKTS:ETST) & Alterity Therapeutics (NASDAQ:ATHE) Head-To-Head Review

Earth Science Tech (OTCMKTS:ETST) and Alterity Therapeutics (NASDAQ:ATHE) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their dividends, valuation, institutional ownership, earnings, profitability, risk and analyst recommendations.

Institutional and Insider Ownership

2.1% of Alterity Therapeutics shares are held by institutional investors. 24.9% of Earth Science Tech shares are held by company insiders. Comparatively, 38.8% of Alterity Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Volatility & Risk

Earth Science Tech has a beta of 1.91, suggesting that its stock price is 91% more volatile than the S&P 500. Comparatively, Alterity Therapeutics has a beta of 0.61, suggesting that its stock price is 39% less volatile than the S&P 500.

Valuation and Earnings

This table compares Earth Science Tech and Alterity Therapeutics”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Earth Science Tech	$11.95 million	3.61	$810,000.00	N/A	N/A
Alterity Therapeutics	N/A	N/A	-$12.54 million	N/A	N/A

Earth Science Tech has higher revenue and earnings than Alterity Therapeutics.

Analyst Ratings

This is a breakdown of current ratings for Earth Science Tech and Alterity Therapeutics, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Earth Science Tech	0	0	0	0	0.00
Alterity Therapeutics	0	1	1	0	2.50

Alterity Therapeutics has a consensus price target of $8.00, suggesting a potential upside of 124.09%. Given Alterity Therapeutics’ stronger consensus rating and higher possible upside, analysts clearly believe Alterity Therapeutics is more favorable than Earth Science Tech.

Profitability

This table compares Earth Science Tech and Alterity Therapeutics’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Earth Science Tech	N/A	N/A	N/A
Alterity Therapeutics	N/A	N/A	N/A

Summary

Alterity Therapeutics beats Earth Science Tech on 5 of the 8 factors compared between the two stocks.

About Earth Science Tech

Earth Science Tech, Inc. focuses on health and wellness industry. It operates men's health telemedicine platform under brand Peak name; and operates pharmacy. The company offers supplements and topicals products. The company was formerly known as Ultimate Novelty Sports, Inc. and changed its name to Earth Science Tech, Inc. in March 2014. Earth Science Tech, Inc. was incorporated in 2010 and is headquartered in Miami, Florida.

About Alterity Therapeutics

Alterity Therapeutics Limited engages in the research and development of therapeutic drugs to treat Alzheimer’s disease, Huntington disease, Parkinson’s disease, and other neurological disorders in Australia. The company’s lead drug candidate is ATH434 that is in Phase I clinical trial for the treatment of Parkinson’s disease. It is also developing ATH434-201, which is in Phase II clinical trial to treat multiple system atrophy early stage; ATH434-202 that is in Phase II clinical trial to treat multiple system atrophy advance; and PBT2 that has completed Phase 2a clinical trial to treat Alzheimer’s disease. The company was formerly known as Prana Biotechnology Limited and changed its name to Alterity Therapeutics Limited in April 2019. Alterity Therapeutics Limited was incorporated in 1997 and is headquartered in Melbourne, Australia.